Informationen:
Fehler:
ID
23807
Beschreibung
Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum https://clinicaltrials.gov/ct2/show/NCT00077233
Link
https://clinicaltrials.gov/ct2/show/NCT00077233
Stichworte
Versionen (2)
- 27.08.12 27.08.12 -
- 14.07.17 14.07.17 - Martin Dugas
Hochgeladen am
14. Juli 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Metastatic Colorectal Cancer Fluorouracil Leucovorin Irinotecan Oxaliplatin NCT00077233 CALGB 80203
No Instruction available.
- StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
Ähnliche Modelle
No Instruction available.
- StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Patient Hospital Number
Item
Patient Hospital No.
text
C0421459 (UMLS CUI [1])
Institution/Affiliate
Item
Institution/Affiliate
text
C1301943 (UMLS CUI [1])
Participating Group
Item
Participating Group
text
C2347449 (UMLS CUI [1])
Participating Group Protocol Number
Item
Participating Group Protocol No.
text
C3274381 (UMLS CUI [1,1])
C2347449 (UMLS CUI [1,2])
C2347449 (UMLS CUI [1,2])
Participating Group Patient ID
Item
Participating Group Patient ID
text
C2348585 (UMLS CUI [1])
CALGB Study Number
Item
CALGB Study No.
text
C3274381 (UMLS CUI [1,1])
C1516238 (UMLS CUI [1,2])
C1516238 (UMLS CUI [1,2])
CALGB Patient ID
Item
CALGB Patient ID
text
C2348585 (UMLS CUI [1,1])
C1516238 (UMLS CUI [1,2])
C1516238 (UMLS CUI [1,2])
Data amended
Item
Are data amended
boolean
C1691222 (UMLS CUI [1])
Item Group
Cetuximab Skin Toxicities
C0995188 (UMLS CUI-1)
C1167791 (UMLS CUI-2)
C1167791 (UMLS CUI-2)
No adverse event
Item
Mark with an X if there are none
boolean
C1963761 (UMLS CUI [1])
MedDRA
Item
MedDRA
text
C1140263 (UMLS CUI [1])
CL Item
Rash/desquamation (1)
C1559142 (UMLS CUI-1)
CL Item
Pruritus (2)
C0033774 (UMLS CUI-1)
CL Item
Erythema multiforme (3)
C0014742 (UMLS CUI-1)
CL Item
Nail changes (4)
C0234909 (UMLS CUI-1)
CL Item
Dry skin (5)
C0151908 (UMLS CUI-1)
CL Item
Other, specify (6)
C3845569 (UMLS CUI-1)
Other,specify
Item
Other, specify
text
C3845569 (UMLS CUI [1])
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Item
Cetuximab Dose Modification
integer
C0995188 (UMLS CUI [1,1])
C1707811 (UMLS CUI [1,2])
C1707811 (UMLS CUI [1,2])
CL Item
Dose held (1)
C0178602 (UMLS CUI-1)
C0549178 (UMLS CUI-2)
C0549178 (UMLS CUI-2)
CL Item
Dose reduced (2)
C1707814 (UMLS CUI-1)
CL Item
Drug discontinued (3)
C0558681 (UMLS CUI-1)
Adverse event onset date
Item
Adverse event onset date
date
C2985916 (UMLS CUI [1])
Adverse event end date
Item
Adverse event end date
date
C2697886 (UMLS CUI [1])
Adverse event ongoing
Item
If ongoing mark with an X
boolean
C2826663 (UMLS CUI [1])
Completed by
Item
Completed by
text
C1550483 (UMLS CUI [1])
Date form originally completed
Item
Date form originally completed
date
C1549507 (UMLS CUI [1])